©2025 Stanford Medicine
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
Not Recruiting
Trial ID: NCT03125629
Purpose
This clinical trial studies how well positron emission tomography (PET)/computed tomography (CT) works compared to PET/magnetic resonance imaging (MRI) in evaluating patients with cancer. PET/CT and PET/MRI may determine which scanner is best for the patient's type of cancer and other types of cancers.
Official Title
Comparison of PET/CT vs. PET/MRI
Stanford Investigator(s)
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
Eligibility
INCLUSION CRITERIA
* Cancer diagnosis
* Capable of complying with study procedures
* Able to remain still for duration of imaging procedure (approximately 90 minutes total)
* Written informed consent
EXCLUSION CRITERIA
* Pregnant or nursing
* Metallic implants
* Impaired renal function
Intervention(s):
drug: Ga-68-DOTA-TATE
drug: F-18 FDG
device: Positron Emission Tomography / Computed Tomography (PET/CT) Scan
device: Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Scan
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305